Polyamines from myeloid-derived suppressor cells promote Th17 polarization and disease progression: Molecular Therapy

Por um escritor misterioso

Descrição

Polyamines from myeloid-derived suppressor cells promote Th17 polarization  and disease progression: Molecular Therapy
De novo synthesis and salvage pathway coordinately regulate
Polyamines from myeloid-derived suppressor cells promote Th17 polarization  and disease progression: Molecular Therapy
Cells, Free Full-Text
Polyamines from myeloid-derived suppressor cells promote Th17 polarization  and disease progression: Molecular Therapy
Implications of metabolism-driven myeloid dysfunctions in cancer
Polyamines from myeloid-derived suppressor cells promote Th17 polarization  and disease progression: Molecular Therapy
Frontline Science: Induction of experimental autoimmune
Polyamines from myeloid-derived suppressor cells promote Th17 polarization  and disease progression: Molecular Therapy
The correlation between the Th17/Treg cell balance and bone health
Polyamines from myeloid-derived suppressor cells promote Th17 polarization  and disease progression: Molecular Therapy
Myeloid‐derived suppressor cells in the therapy of autoimmune
Polyamines from myeloid-derived suppressor cells promote Th17 polarization  and disease progression: Molecular Therapy
Full article: Myeloid-derived suppressor cells prevent disruption
Polyamines from myeloid-derived suppressor cells promote Th17 polarization  and disease progression: Molecular Therapy
Full article: Myeloid-derived suppressor cells prevent disruption
Polyamines from myeloid-derived suppressor cells promote Th17 polarization  and disease progression: Molecular Therapy
Polyamines from myeloid-derived suppressor cells promote Th17
Polyamines from myeloid-derived suppressor cells promote Th17 polarization  and disease progression: Molecular Therapy
Polyamines drive myeloid cell survival by buffering intracellular
de por adulto (o preço varia de acordo com o tamanho do grupo)